Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
about
Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoidsA novel nuclear receptor corepressor complex, N-CoR, contains components of the mammalian SWI/SNF complex and the corepressor KAP-1Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functionsThe PGC-1-related protein PERC is a selective coactivator of estrogen receptor alphaSuppression of estrogen receptor-mediated transcription and cell growth by interaction with TR2 orphan receptorRepressors of androgen and progesterone receptor actionLigand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cellsThe opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor bindingMetastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulatorDirect visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptorEstrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapyEndocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?Evidence that 17alpha-estradiol is biologically active in the uterine tissue: antiuterotonic and antiuterotrophic action.Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancerMechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNAA peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiationCrystallographic comparison of the estrogen and progesterone receptor's ligand binding domainsAntiestrogens: structure-activity relationships and use in breast cancer treatmentJAB1 interacts with both the progesterone receptor and SRC-1MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functionsT:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alphaCoactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cellsMolecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptorsRU486-induced glucocorticoid receptor agonism is controlled by the receptor N terminus and by corepressor bindingThe nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor.Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analoguesRecruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactionsIdentification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitorSteroid receptor coactivator-1 from brain physically interacts differentially with steroid receptor subtypesSteroid receptor coactivator-2 expression in brain and physical associations with steroid receptorsTransgenic targeting of a dominant negative corepressor to liver blocks basal repression by thyroid hormone receptor and increases cell proliferationTruncated estrogen receptor product-1 stimulates estrogen receptor alpha transcriptional activity by titration of repressor proteinsTruncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors alpha and beta.Bazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease.Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice.
P2860
Q22009969-1ACC590F-D9E8-4B97-B6D8-D32D34573684Q24290346-050D7AA1-DB28-4E7D-8E93-31BFDB70FFFEQ24291233-FF3AC3DE-1411-48DC-9BD2-D2751B0ECAFDQ24292329-E68F13A5-4ABA-4B99-A534-84D429A48A5EQ24300794-88E3BE22-3C69-4D3A-B344-6F54A873820EQ24303288-B0A1145F-7565-4288-ADE4-53079FAA97EEQ24541489-47E0D379-D997-4C7E-A07E-3B7D1837A873Q24554243-AB6375B2-BCC8-4129-BF31-6C933D995357Q24564251-C133E14A-BE9C-461B-84D7-64B16CA98D48Q24643098-FE45E6F5-E375-4816-8B24-67ACDAB26E01Q24800731-4CCB8AA4-F3C5-49F8-9A01-7A14AD5310A3Q24803990-DCE031A1-62CA-4479-A70D-3CA016458DDBQ24810287-1201BA51-47C6-4BAA-8F91-E20EE921B9BAQ24812462-29B4FEE0-605A-4963-B83C-728C4AD301D0Q24813627-E182066C-7CA0-42B9-AD83-A48C0AB2AD12Q27011221-ECBF0298-1AD0-48B6-AFD9-07F808822337Q27618352-889A8AA8-D47A-49F5-9035-4EF5489680B8Q27757822-C6384703-47BA-45C8-BDAE-9D2D6347744BQ28077245-9ED909F8-B9EB-4DE2-88F1-3D06D8334E86Q28139007-7239F831-383A-4ED5-BAFC-18571723C231Q28183743-02C374CF-4BC9-4CA3-A098-0DCA36A6C649Q28188710-2517D368-0BD5-4362-8690-8929969911C6Q28202581-D04B310C-E970-4153-AFE6-6C2090F94317Q28203389-AA50FC8E-1BED-4147-BE30-6EABD5ADCB31Q28204785-0A755E2C-565E-4A31-A512-086AE8301623Q28217579-9C55B3D6-3FDF-4A05-A2F3-2D519122A9D6Q28263578-3ACD758A-0730-422D-9C62-84BAE00A22F8Q28284917-A4AE146A-9BEF-4ABF-8320-657175D4B036Q28366589-E0F7D1CA-0C60-48EE-A4D0-356E9FEEAD9AQ28377418-5D627005-C19C-4C01-8E25-D2E7EF25831AQ28538014-E1C4B926-8AAF-45F2-ACF7-192C3E3BA908Q28582922-7444E765-6BFE-4658-A017-FF4FFB05B2C1Q28584052-13299047-A7EA-4669-A01C-A335A5F0AE1DQ28594081-58C86227-E6BB-42C3-9D59-6FD3762EA3D3Q28594792-34BFCB62-0C0C-4D91-B05E-03C373A8C0C8Q30305439-82A7CFCE-B687-4622-A17F-9DE3AECEFE70Q30413295-828CEAF4-4244-4F29-9774-9CB09F30B58FQ30559389-990A2A7C-6A93-465D-B66C-39AE923009DEQ30815190-0DC53E18-C280-4000-B953-B7CDC94E6F35Q33287050-380C6A4F-C165-41A1-B1D1-3207A29F1251
P2860
Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Coactivator and corepressor re ...... iestrogen, 4-hydroxytamoxifen.
@en
Coactivator and corepressor re ...... iestrogen, 4-hydroxytamoxifen.
@nl
type
label
Coactivator and corepressor re ...... iestrogen, 4-hydroxytamoxifen.
@en
Coactivator and corepressor re ...... iestrogen, 4-hydroxytamoxifen.
@nl
prefLabel
Coactivator and corepressor re ...... iestrogen, 4-hydroxytamoxifen.
@en
Coactivator and corepressor re ...... iestrogen, 4-hydroxytamoxifen.
@nl
P2093
P356
P1476
Coactivator and corepressor re ...... iestrogen, 4-hydroxytamoxifen.
@en
P2093
P304
P356
10.1210/ME.11.6.657
P577
1997-06-01T00:00:00Z